← back to search

Anastasia Tsakmaki

King's College London · GB
Area of research
Genetics · Surgery
Research interest
Research interests include Pancreatic function and diabetes, Inflammatory Bowel Disease, Diabetes and associated disorders, and Digestive system and related health.
h-index
14
citations
865
works
33
NIH funding
primary concept
email

Recent publications

Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy
Nature Communications 2022cited by 128position: middledoi
Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease
Cell Reports 2022cited by 40position: middledoi
Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
Scientific Reports 2020cited by 44position: middledoi
ISX-9 manipulates endocrine progenitor fate revealing conserved intestinal lineages in mouse and human organoids
Molecular Metabolism 2020cited by 38position: firstdoi
Diabetes through a 3D lens: organoid models
Diabetologia 2020cited by 36position: firstdoi
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Gut 2019cited by 152position: middledoi
Modelling pancreatic β-cell inflammation in zebrafish identifies the natural product wedelolactone for human islet protection
Disease Models & Mechanisms 2019cited by 35position: middledoi
Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish
eLife 2018cited by 35position: middledoi
Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
Molecular Metabolism 2016cited by 250position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gavin A. Bewick · King's College London9 papers (2016–2022)Polychronis Pavlidis · King's College - North Carolina4 papers (2019–2022)Domenico Cozzetto · British Heart Foundation3 papers (2019–2022)Joshua R. Friedman · Spark Therapeutics (United States)3 papers (2019–2022)Feifei Yang · Xi'an University of Science and Technology3 papers (2019–2022)Nick Powell · Indiana University – Purdue University Indianapolis3 papers (2019–2022) · 2 papers (2018–2019)Bu Hayee · King's College London2 papers (2020–2022)Umar Niazi · NIHR Evaluation Trials and Studies Coordinating Centre2 papers (2022–2022)Patricia Fonseca Pedro · King's College London2 papers (2020–2020)Émilie Stolarczyk · Abcam (United States)2 papers (2016–2019)Thomas T. MacDonald · Queen Mary University of London2 papers (2019–2022) · 2 papers (2022–2022)Graham M. Lord · King's College London2 papers (2019–2022) · 2 papers (2022–2022)Katherine Li · Johnson & Johnson (United States)2 papers (2019–2022)Eirini Pantazi · Oxford BioMedica (United Kingdom)2 papers (2019–2022)Jonathan Digby‐Bell · Royal Devon & Exeter NHS Foundation Trust2 papers (2019–2022)Mansoor Saqi · Université Claude Bernard Lyon 12 papers (2022–2022)Nikolay Ninov · Deutsches Diabetes-Zentrum e.V.2 papers (2018–2019)